The amino acid tryptophan was often depleted in the tumor microenvironment due to its catabolism by tryptophan 2,3-dioxygenase (TDO2) or indoleamine 2,3-dioxygenase (IDO1), resulting in the production of kynurenine. Here, TDO2 is linked to neoplasm.